FIPRA INTERNATIONAL SRL
Desconocido
e-FabRIC: enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy...
FIPRA INTERNATIONAL SRL
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2023-DISEASE-03
E-FabRIC will develop a new hyperimmunization strategy for generating high titers equine immunoglobulins having a broad neutralizing specifi...
2023-12-07 - 2027-11-30 | Financiado
2023-12-07 - 2027-11-30 | Financiado
PEERS: PracticE Ecosystem for standaRdS
FIPRA INTERNATIONAL SRL
participó en un
HORIZON EUROPE:
HORIZON-CL3-2021-DRS-01
The overall objective of PEERS is to advance and reinforce existing policy through practitioner-driven pre-normative standardisation process...
2022-10-14 - 2025-10-31 | Financiado
2022-10-14 - 2025-10-31 | Financiado
* No se disponen de datos de la empresa actual.